Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Acquisition strategy (1)
- Acquisitions (1)
- Africa (1)
- Alzheimer's Disease (1)
- Biopharmaceutical Industry (1)
-
- Biotechnology (1)
- CEO Demographics (1)
- Central Nervous System (1)
- Chevron Corporation (1)
- Corruption (1)
- Energy industry (1)
- External environment (1)
- Growth strategy (1)
- Keywords: Political stability (1)
- Merck (1)
- Novavax (1)
- Performance (1)
- Pharmaceutical industry analysis (1)
- Roche Pharmaceuticals (1)
- SM Energy (1)
- Technological assessment (1)
Articles 1 - 4 of 4
Full-Text Articles in Business
The Role Of Politics And Corruption In The Rise Of The African Firm, Wedu Ketema, Howard Jean-Denis
The Role Of Politics And Corruption In The Rise Of The African Firm, Wedu Ketema, Howard Jean-Denis
Seaver College Research And Scholarly Achievement Symposium
Many African businesses lag in financial performance compared to the performance of companies in the West. Despite this, the continent’s economic output has continued to rise considerably in the past two decades, but many of these economic achievements have been discredited. Despite the West’s view of Africa as a continent unprepared for economic growth due to simmering conflict, threats of terror, and other barriers to business, African business has continued to boom. Over the past two decades, Africa has made massive strides to “catch up to the West.” In fact, according to experts, many countries in Africa have experienced what …
Central Nervous System Strategy For Roche Pharmaceuticals, Kali A. Jelen
Central Nervous System Strategy For Roche Pharmaceuticals, Kali A. Jelen
Seaver College Research And Scholarly Achievement Symposium
Roche is the fifth largest pharmaceutical and biotechnology company in the world with $52B in sales during 2013 and 4.9% market share in the pharmaceutical industry. Its main competitors include Novartis, Pfizer, Johnson & Johnson, Sanofi, Merck & Co., and GlaxoSmithKline. Roche’s mission is to develop treatments for medical needs that have gone unmet and to create more efficient treatment options through cutting edge research. The Central Nervous System market segment makes up 19.6% of total industry sales and includes products treating such ailments as depression, epilepsy, psychosis, and Alzheimer’s disease. Though historically Roche has been a market leader in …
Pharmaceutical Industry Analysis, External Environment, And Technological Assessment For The Development Of An Acquisition Strategy (Novavax), Jessica Freitas, Miluska Mogrovejo
Pharmaceutical Industry Analysis, External Environment, And Technological Assessment For The Development Of An Acquisition Strategy (Novavax), Jessica Freitas, Miluska Mogrovejo
Seaver College Research And Scholarly Achievement Symposium
At the end of 2012, Merck’s Net Sales totaled $47.27 B. The company’s Total Global Pharmaceutical Industry’s Share of Market (SOM) is about 4.3%, making it the seventh largest in the industry as of 2012. Merck’s biggest competitors include, Johnson & Johnson, Pfizer Inc., Novartis AG, Bayer AG, Roche Holding Ltd, and Sanofi. In order for Merck to maintain its U.S. and Global Market Share, sustain competitive advantage against its competitors, and maximize its Shareholder Wealth, it must assess its Environmental Threats and Opportunities. Merck greatest Threats are Competition, especially from generic products that devalue Merck’s brand drugs that lose …
The Acquisition Of Sm Energy As A Proposed Strategy Of Growth For Chevron Corporation, Lindsay G. Gardner
The Acquisition Of Sm Energy As A Proposed Strategy Of Growth For Chevron Corporation, Lindsay G. Gardner
Seaver College Research And Scholarly Achievement Symposium
The Energy Industry is worth $7.5 Trillion. As traditional sources of energy production become more costly to obtain due to scarcity of natural resources and a volatile international political climate, it is imperative that the United States be able to self-sufficiently produce sustainable energy. Chevron Corp. is a global company in the Energy Industry with Net Sales of $230.09 B and a market share of 3.60% in 2012. Extensive analysis of the External Industry Environment and a Company Assessment lead to the formation of the acquisition of SM Energy as a proposed strategy for Chevron Corp. growth. The acquisition would …